Cancer cell lines and tumours harbouring mutations in exon 11 of BRCA1 express a BRCA1-Δ11q splice variant lacking the majority of exon 11 but retains partial BRCA activity, mediating PARPi resistance [21]. Here, BRCA1 is linked to neoplasm.